Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ NAV2 Monoclonal Antibody (4D11)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA522827

Catalog No. PIMA522827


Only null left
Add to Cart

Description

Description

Peptide Sequence: TGSTPLLRNS HSNSLISECM DSEAETVMQL RNELRDKEMK LTDIRLEALS SAHQLDQLRE AMNRMQSEIE KLKAENDRLK SESQGSGCSR APSQVS.

The vitamin A metabolite, all-trans retinoic acid (atRA), plays an important role in neuronal development, including neurite outgrowth. RAINB1 is an atRA-responsive gene. [supplied by OMIM].
TRUSTED_SUSTAINABILITY
Specifications

Specifications

NAV2
Monoclonal
1 mg/mL
PBS with no preservative; pH 7.4
Q8IVL1
NAV2
NAV2 (NP_892009.2, 1878 a.a. ~ 1973 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
100 μg
Primary
Human
Antibody
IgG2a κ
ELISA, Western Blot
4D11
Unconjugated
NAV2
5330421F07Rik; AU067780; BQ960892; HELAD1; Helicase APC down-regulated 1; helicase, APC down-regulated 1; KIAA1419; mKIAA3015; NAV2; Neuron navigator 2; POMFIL2; Pore membrane and/or filament-interacting-like protein 2; RAINB1; RAINB2; retinoic acid inducible gene in neuroblastoma 1; retinoic acid inducible in neuroblastoma; Retinoic acid inducible in neuroblastoma 1; STEERIN2; Steerin-2; Unc-53 homolog 2; UNC53H2
Mouse
Affinity Chromatography
RUO
89797
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.